Journal Article

Identifying patients at risk of coronary vascular disease: the potential role of inflammatory markers

C. Kluft

in European Heart Journal Supplements

Published on behalf of European Society of Cardiology

Volume 6, issue suppl_C, pages C21-C27
Published in print July 2004 | ISSN: 1520-765X
Published online July 2004 | e-ISSN: 1554-2815 | DOI:
Identifying patients at risk of coronary vascular disease: the potential role of inflammatory markers

Show Summary Details


Inflammation is intimately involved in the pathogenesis of cardiovascular disease (CVD). The measurement of inflammatory markers may be a potent method for identifying individuals with increased inflammation at risk of future cardiovascular events. High-sensitivity C-reactive protein (hs-CRP), one marker of inflammation, is a strong independent predictor of CVD and can be used to identify individuals at increased risk who would otherwise be missed if standard lipid measurements only were used. Furthermore, CRP may actively participate in the pathogenic progression of atherosclerotic disease by activating complement, inducing synthesis of tissue factor, influencing nitric oxide levels, and enhancing foam cell uptake of low-density lipoprotein cholesterol. Simple, inexpensive methods for measuring hs-CRP are commercially available, making the measurement of CRP levels feasible in clinical settings. Together, these data suggest that the ability to accurately predict CVD risk may be significantly increased by including CRP measurements in risk assessment models. In addition, the identification of increased inflammation suggests that rational therapy should be applied and favours treatments with anti-inflammatory action.

Keywords: Cardiovascular disease; C-reactive protein; Inflammation; Inflammatory markers; Risk factor assessment; Statins

Journal Article.  4534 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.